Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 239

1.

Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD.

Navaneethan SD, Akeroyd JM, Ramsey D, Ahmed ST, Mishra SR, Petersen LA, Muntner P, Ballantyne C, Winkelmayer WC, Ramanathan V, Virani SS.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1842-1850. doi: 10.2215/CJN.03830318. Epub 2018 Nov 29.

PMID:
30498000
2.

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J.

J Am Coll Cardiol. 2018 Nov 8. pii: S0735-1097(18)39034-X. doi: 10.1016/j.jacc.2018.11.003. [Epub ahead of print] No abstract available.

PMID:
30423393
3.

Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology.

Lloyd-Jones DM, Braun LT, Ndumele CE, Smith SC Jr, Sperling LS, Virani SS, Blumenthal RS.

J Am Coll Cardiol. 2018 Nov 3. pii: S0735-1097(18)39036-3. doi: 10.1016/j.jacc.2018.11.005. [Epub ahead of print]

PMID:
30423392
4.

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J.

J Am Coll Cardiol. 2018 Nov 3. pii: S0735-1097(18)39033-8. doi: 10.1016/j.jacc.2018.11.002. [Epub ahead of print] No abstract available.

PMID:
30423391
5.

Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences.

Navar AM, Wang TY, Mi X, Robinson JG, Virani SS, Roger VL, Wilson PWF, Goldberg AC, Peterson ED.

JAMA Cardiol. 2018 Nov 7. doi: 10.1001/jamacardio.2018.3680. [Epub ahead of print]

PMID:
30419113
6.

Electronic health records and outpatient cardiovascular disease care delivery: Insights from the American College of Cardiology's PINNACLE India Quality Improvement Program (PIQIP).

Kalra A, Bhatt DL, Wei J, Anderson KL, Rykowski S, Kerkar PG, Kumar G, Maddox TM, Oetgen WJ, Virani SS.

Indian Heart J. 2018 Sep - Oct;70(5):750-752. doi: 10.1016/j.ihj.2018.03.002. Epub 2018 Mar 7.

7.

Epidemiologic studies targeting primary cardiovascular disease prevention in South Asia.

Rehman H, Samad Z, Mishra SR, Merchant AT, Narula JP, Mishra S, Virani SS.

Indian Heart J. 2018 Sep - Oct;70(5):721-730. doi: 10.1016/j.ihj.2018.01.029. Epub 2018 Jan 31. Review.

8.

Lipid-Lowering Therapies: Risks in Women and Evidence-Based Options.

Shah T, Virani SS.

Tex Heart Inst J. 2018 Aug 1;45(4):238-239. doi: 10.14503/THIJ-18-6691. eCollection 2018 Aug. Review. No abstract available.

9.

Measurement of Low-Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry.

Lowenstern AM, Li S, Navar AM, Roger VL, Robinson JG, Goldberg AC, Virani SS, Lee LV, Wilson PWF, Louie MJ, Peterson ED, Wang TY.

J Am Heart Assoc. 2018 Sep 18;7(18):e009251. doi: 10.1161/JAHA.118.009251.

10.

Case reports of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition nonresponse.

Saeed A, Virani SS, Jones PH, Ballantyne CM, Nambi V.

J Clin Lipidol. 2018 Sep - Oct;12(5):1141-1145. doi: 10.1016/j.jacl.2018.05.017. Epub 2018 Jun 1.

PMID:
30318064
11.

The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.

Sandesara PB, Virani SS, Fazio S, Shapiro MD.

Endocr Rev. 2018 Oct 11. doi: 10.1210/er.2018-00184. [Epub ahead of print]

PMID:
30312399
12.

Variation in the Use of Warfarin and Direct Oral Anticoagulants in Atrial Fibrillation and Associated Cost Implications.

Rodwin BA, Salami JA, Spatz ES, Valero-Elizondo J, Virani SS, Blankstein R, Blaha MJ, Nasir K, Desai NR.

Am J Med. 2018 Oct 2. pii: S0002-9343(18)30949-5. doi: 10.1016/j.amjmed.2018.09.026. [Epub ahead of print]

PMID:
30290193
13.

Are All Benefits and Harms Equal?

Saeed A, Virani SS, Ballantyne CM, Taylor AA, Nambi V.

J Am Coll Cardiol. 2018 Aug 14;72(7):819-820. doi: 10.1016/j.jacc.2018.05.055. No abstract available.

PMID:
30092962
14.

Anti-Hypertensive Medication Use, Soluble Receptor for Glycation End Products and Risk of Pancreatic Cancer in the Women's Health Initiative Study.

Wang Z, White DL, Hoogeveen R, Chen L, Whitsel EA, Richardson PA, Virani SS, Garcia JM, El-Serag HB, Jiao L.

J Clin Med. 2018 Aug 2;7(8). pii: E197. doi: 10.3390/jcm7080197.

15.

Frequency of Statin Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dl from the Veterans Affairs Health System.

Rodriguez F, Knowles JW, Maron DJ, Virani SS, Heidenreich PA.

Am J Cardiol. 2018 Sep 1;122(5):756-761. doi: 10.1016/j.amjcard.2018.05.008. Epub 2018 Jun 7.

PMID:
30055758
16.

Association between intensity of statin therapy and mortality in persons with chronic kidney disease.

Walther CP, Richardson PA, Virani SS, Winkelmayer WC, Navaneethan SD.

Nephrol Dial Transplant. 2018 Jul 20. doi: 10.1093/ndt/gfy237. [Epub ahead of print]

PMID:
30053252
17.

Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease.

Saeed A, Feofanova EV, Yu B, Sun W, Virani SS, Nambi V, Coresh J, Guild CS, Boerwinkle E, Ballantyne CM, Hoogeveen RC.

J Am Coll Cardiol. 2018 Jul 10;72(2):156-169. doi: 10.1016/j.jacc.2018.04.050.

PMID:
29976289
18.

Effectiveness of NPs and PAs in managing diabetes and cardiovascular disease.

Faza NN, Akeroyd JM, Ramsey DJ, Shah T, Nasir K, Deswal A, Ballantyne CM, Petersen LA, Virani SS.

JAAPA. 2018 Jul;31(7):39-45. doi: 10.1097/01.JAA.0000534983.61613.91.

PMID:
29957606
19.

Incorporating Guideline Adherence and Practice Implementation Issues into the Design of Decision Support for Beta-Blocker Titration for Heart Failure.

Smith MW, Brown C, Virani SS, Weir CR, Petersen LA, Kelly N, Akeroyd J, Garvin JH.

Appl Clin Inform. 2018 Apr;9(2):478-489. doi: 10.1055/s-0038-1660849. Epub 2018 Jun 27.

PMID:
29949816
20.

Life's Simple 7 and the risk of atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis.

Ogunmoroti O, Michos ED, Aronis KN, Salami JA, Blankstein R, Virani SS, Spatz ES, Allen NB, Rana JS, Blumenthal RS, Veledar E, Szklo M, Blaha MJ, Nasir K.

Atherosclerosis. 2018 Aug;275:174-181. doi: 10.1016/j.atherosclerosis.2018.05.050. Epub 2018 Jun 2.

PMID:
29920438
21.

Correction to: Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions.

Saeed A, Dabhadkar K, Virani SS, Jones PH, Ballantyne CM, Nambi V.

Curr Atheroscler Rep. 2018 Jun 19;20(9):42. doi: 10.1007/s11883-018-0743-9.

PMID:
29915890
22.

Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).

Miedema MD, Dardari ZA, Kianoush S, Virani SS, Yeboah J, Knickelbine T, Sandfort V, Rodriguez CJ, Nasir K, Blaha MJ.

J Am Heart Assoc. 2018 Jun 13;7(12). pii: e008920. doi: 10.1161/JAHA.118.008920.

23.

Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry.

Nanna MG, Navar AM, Zakroysky P, Xiang Q, Goldberg AC, Robinson J, Roger VL, Virani SS, Wilson PWF, Elassal J, Lee LV, Wang TY, Peterson ED.

JAMA Cardiol. 2018 Aug 1;3(8):739-748. doi: 10.1001/jamacardio.2018.1511.

PMID:
29898219
24.

Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry.

Basra SS, Wang TY, Simon DN, Chiswell K, Virani SS, Alam M, Nambi V, Denktas AE, Deswal A, Bozkurt B, Ballantyne CM, Peterson ED, Jneid H.

J Am Heart Assoc. 2018 Jun 9;7(12). pii: e008125. doi: 10.1161/JAHA.117.008125.

25.

Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions.

Saeed A, Dabhadkar K, Virani SS, Jones PH, Ballantyne CM, Nambi V.

Curr Atheroscler Rep. 2018 May 21;20(7):35. doi: 10.1007/s11883-018-0735-9. Review. Erratum in: Curr Atheroscler Rep. 2018 Jun 19;20(9):42.

PMID:
29781057
26.

Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.

Virani SS, Kennedy KF, Akeroyd JM, Morris PB, Bittner VA, Masoudi FA, Stone NJ, Petersen LA, Ballantyne CM.

Circ Cardiovasc Qual Outcomes. 2018 May;11(5):e004652. doi: 10.1161/CIRCOUTCOMES.118.004652.

PMID:
29748356
27.

Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.

Nanna MG, Navar AM, Wang TY, Mi X, Virani SS, Louie MJ, Lee LV, Goldberg AC, Roger VL, Robinson J, Peterson ED.

J Am Heart Assoc. 2018 May 8;7(10). pii: e008546. doi: 10.1161/JAHA.118.008546.

28.

High-density lipoprotein cholesterol and causes of death in chronic kidney disease.

Navaneethan SD, Schold JD, Walther CP, Arrigain S, Jolly SE, Virani SS, Winkelmayer WC, Nally JV Jr.

J Clin Lipidol. 2018 Jul - Aug;12(4):1061-1071.e7. doi: 10.1016/j.jacl.2018.03.085. Epub 2018 Mar 30.

PMID:
29699917
29.

Favorable Modifiable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs Among Cancer Patients: The 2012-2013 Medical Expenditure Panel Survey.

Singh J, Valero-Elizondo J, Salami JA, Warraich HJ, Ogunmoroti O, Spatz ES, Desai N, Rana JS, Virani SS, Blankstein R, Blaha MJ, Nasir K.

J Am Heart Assoc. 2018 Apr 23;7(9). pii: e007874. doi: 10.1161/JAHA.117.007874.

30.

Impact of Patient-Centered Medical Home Implementation on Diabetes Control in the Veterans Health Administration.

Woodard LD, Adepoju OE, Amspoker AB, Virani SS, Ramsey DJ, Petersen LA, Jones LA, Kiefer L, Mehta P, Naik AD.

J Gen Intern Med. 2018 Aug;33(8):1276-1282. doi: 10.1007/s11606-018-4386-x. Epub 2018 Apr 2.

PMID:
29611089
31.

Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs.

McBride CL, Akeroyd JM, Ramsey DJ, Nambi V, Nasir K, Michos ED, Bush RL, Jneid H, Morris PB, Bittner VA, Ballantyne CM, Petersen LA, Virani SS.

Vasc Med. 2018 Jun;23(3):232-240. doi: 10.1177/1358863X18758914. Epub 2018 Mar 30.

PMID:
29600737
32.

Aberrant Course of Pacemaker Leads: When Left is Left.

Faza NN, Virani SS, Nambi V, Shah T.

Tex Heart Inst J. 2018 Feb 1;45(1):52-53. doi: 10.14503/THIJ-16-6170. eCollection 2018 Feb. No abstract available.

33.

Short-Term Global Cardiovascular Disease Risk Prediction in Older Adults.

Saeed A, Nambi V, Sun W, Virani SS, Taffet GE, Deswal A, Selvin E, Matsushita K, Wagenknecht LE, Hoogeveen R, Coresh J, de Lemos JA, Ballantyne CM.

J Am Coll Cardiol. 2018 Jun 5;71(22):2527-2536. doi: 10.1016/j.jacc.2018.02.050. Epub 2018 Mar 10.

PMID:
29535064
34.

Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.

Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, de Ferranti SD, Ferguson JF, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Lutsey PL, Mackey JS, Matchar DB, Matsushita K, Mussolino ME, Nasir K, O'Flaherty M, Palaniappan LP, Pandey A, Pandey DK, Reeves MJ, Ritchey MD, Rodriguez CJ, Roth GA, Rosamond WD, Sampson UKA, Satou GM, Shah SH, Spartano NL, Tirschwell DL, Tsao CW, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee.

Circulation. 2018 Mar 20;137(12):e67-e492. doi: 10.1161/CIR.0000000000000558. Epub 2018 Jan 31. Review. No abstract available. Erratum in: Circulation. 2018 Mar 20;137(12 ):e493.

PMID:
29386200
35.

Premature Coronary Heart Disease in South Asians: Burden and Determinants.

Ahmed ST, Rehman H, Akeroyd JM, Alam M, Shah T, Kalra A, Virani SS.

Curr Atheroscler Rep. 2018 Jan 27;20(1):6. doi: 10.1007/s11883-018-0706-1. Review.

PMID:
29374801
36.

National Trends in Nonstatin Use and Expenditures Among the US Adult Population From 2002 to 2013: Insights From Medical Expenditure Panel Survey.

Salami JA, Warraich HJ, Valero-Elizondo J, Spatz ES, Desai NR, Rana JS, Virani SS, Blankstein R, Khera A, Blaha MJ, Blumenthal RS, Katzen BT, Lloyd-Jones D, Krumholz HM, Nasir K.

J Am Heart Assoc. 2018 Jan 22;7(2). pii: e007132. doi: 10.1161/JAHA.117.007132.

37.

Clinical pharmacist understanding of the 2013 American College of Cardiology/American Heart Association cholesterol guideline.

Bucheit JD, Helsing H, Nadpara P, Virani SS, Dixon DL.

J Clin Lipidol. 2018 Mar - Apr;12(2):367-374.e3. doi: 10.1016/j.jacl.2017.11.010. Epub 2017 Dec 6.

PMID:
29277495
38.

Persistent socioeconomic disparities in cardiovascular risk factors and health in the United States: Medical Expenditure Panel Survey 2002-2013.

Valero-Elizondo J, Hong JC, Spatz ES, Salami JA, Desai NR, Rana JS, Khera R, Virani SS, Blankstein R, Blaha MJ, Nasir K.

Atherosclerosis. 2018 Feb;269:301-305. doi: 10.1016/j.atherosclerosis.2017.12.014. Epub 2017 Dec 8.

PMID:
29254694
39.

Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study.

Aronis KN, Zhao D, Hoogeveen RC, Alonso A, Ballantyne CM, Guallar E, Jones SR, Martin SS, Nazarian S, Steffen BT, Virani SS, Michos ED.

J Am Heart Assoc. 2017 Dec 15;6(12). pii: e007372. doi: 10.1161/JAHA.117.007372.

40.

Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: An NCDR Research to Practice (R2P) project.

Hess PL, Kennedy K, Cowherd M, Virani SS, Masoudi FA, Navar AM, Yeh RW, Ho PM, Maddox TM.

Am Heart J. 2018 Jan;195:151-152. doi: 10.1016/j.ahj.2017.09.004. Epub 2017 Sep 9. No abstract available.

PMID:
29224643
41.

Burden of Catastrophic Health Expenditures for Acute Myocardial Infarction and Stroke Among Uninsured in the United States.

Khera R, Hong JC, Saxena A, Arrieta A, Virani SS, Blankstein R, de Lemos JA, Krumholz HM, Nasir K.

Circulation. 2018 Jan 23;137(4):408-410. doi: 10.1161/CIRCULATIONAHA.117.030128. Epub 2017 Nov 13. No abstract available.

PMID:
29133601
42.

Association of low-density lipoprotein pattern with mortality after myocardial infarction: Insights from the TRIUMPH study.

Pokharel Y, Tang Y, Bhardwaj B, Patel KK, Qintar M, O'Keefe JH Jr, Kulkarni KR, Jones PH, Martin SS, Virani SS, Spertus JA.

J Clin Lipidol. 2017 Nov - Dec;11(6):1458-1470.e4. doi: 10.1016/j.jacl.2017.09.002. Epub 2017 Oct 3.

43.

Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers: Insights Derived From the FOURIER Trial.

Arrieta A, Hong JC, Khera R, Virani SS, Krumholz HM, Nasir K.

JAMA Cardiol. 2017 Dec 1;2(12):1369-1374. doi: 10.1001/jamacardio.2017.3655.

44.

Health Care Resource Utilization for Outpatient Cardiovascular Disease and Diabetes Care Delivery Among Advanced Practice Providers and Physician Providers in Primary Care.

Virani SS, Akeroyd JM, Ramsey DJ, Deswal A, Nasir K, Rajan SS, Ballantyne CM, Petersen LA.

Popul Health Manag. 2018 Jun;21(3):209-216. doi: 10.1089/pop.2017.0090. Epub 2017 Oct 10.

PMID:
28994631
45.

Use of cardiopulmonary pump support during coronary artery bypass grafting in the high-risk: a meta-analysis.

Yousif A, Addison D, Lakkis N, Rosengart T, Virani SS, Birnbaum Y, Alam M.

Ir J Med Sci. 2018 May;187(2):369-377. doi: 10.1007/s11845-017-1679-8. Epub 2017 Sep 21.

PMID:
28936580
46.

Lipoprotein(a) and cardiovascular disease: current state and future directions for an enigmatic lipoprotein.

Saeed A, Virani SS.

Front Biosci (Landmark Ed). 2018 Jan 1;23:1099-1112. Review.

PMID:
28930591
47.

Meta-Analysis of Comparison of 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Unprotected Left Main Coronary Artery in the Era of Drug-eluting Stents.

Khan MR, Kayani WT, Ahmad W, Hira RS, Virani SS, Hamzeh I, Jneid H, Lakkis N, Alam M.

Am J Cardiol. 2017 Nov 1;120(9):1514-1520. doi: 10.1016/j.amjcard.2017.07.048. Epub 2017 Aug 1.

PMID:
28886851
48.

Facility-level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database.

Rehman H, Akeroyd JM, Ramsey D, Ahmed ST, Merchant AT, Navaneethan SD, Petersen LA, Virani SS.

Clin Cardiol. 2017 Nov;40(11):1055-1060. doi: 10.1002/clc.22769. Epub 2017 Aug 25.

49.

"All hands on deck": An imperative for tackling hypertension in South Asia.

Samad Z, Merchant AT, Narula JS, Virani SS.

Indian Heart J. 2017 Jul - Aug;69(4):430-431. doi: 10.1016/j.ihj.2017.07.005. Epub 2017 Jul 14. No abstract available.

50.

Omega-3 Fatty Acids (Fish Oil) Supplementation and Albuminuria: Not a Slam Dunk.

Navaneethan SD, Virani SS.

J Am Heart Assoc. 2017 Jul 14;6(7). pii: e006020. doi: 10.1161/JAHA.117.006020. No abstract available.

Supplemental Content

Loading ...
Support Center